EvangeliaKalaitzoglouMD

PubMed

• 1 citations
  Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice.
  R Clay Bunn, Reuben Adatorwovor, Rebecca R Smith, Philip D Ray, Sarah E Fields, Alexander R Keeble, Christopher S Fry, Sasidhar Uppuganti, Jeffry S Nyman, John L Fowlk...> ;JBMR Plus. 2023 Nov 1
• Biomechanical Stimulation of Muscle Constructs Influences Phenotype of Bone Constructs by Modulating Myokine Secretion.
  Harshini Suresh Kumar, Edwina N Barnett, John L Fowlkes, Evangelia Kalaitzoglou, Ramkumar T Annamalai> ;JBMR Plus. 2023 Nov 1
• "Exogenous" 5 Alpha Reductase Deficiency: A Case Report.
  Brittany Levy, Seth Teplitsky, Evangelia Kalaitzoglou, Stephen Kahler, Juliann Paige Matheny, Amanda F Saltzman> ;Urology. 2023 Aug 1
• Bringing the Pediatric Endocrine Spanish Speaking Community Together: First Virtual Pediatric Endocrine Meeting in Low- and Middle-Income Countries in Central and Sout...
  Roberto Bogarin, Luis Elizondo, Evangelia Kalaitzoglou, Jadranka Popovic, Alan Rogol, Erick Richmond, Jean-Pierre Chanoine, Jose M Lopez-Pedrosa, Francis Ruiz Salazar,...> ;Interactive Journal of Medical Research. 2023 May 8
• Ten-Year Experience of a Global and Freely Accessible e-Learning Website for Pediatric Endocrinology and Diabetes.
  Sze May Ng, Evangelia Kalaitzoglou, Agustini Utari, Conny van Wijngaard-de Vugt, Malcolm Donaldson, Joseph I Wolfsdorf, Annemieke M Boot, Stenvert Drop> ;Hormone Research in Paediatrics. 2023 Jan 1
• 3 citations
  Mouse models of type 1 diabetes and their use in skeletal research.
  Evangelia Kalaitzoglou, John L Fowlkes, Kathryn M Thrailkill> ;Current Opinion in Endocrinology, Diabetes, and Obesity. 2022 Aug 1
• 2 citations
  Emerging therapies for the treatment of rare pediatric bone disorders.
  Kathryn M Thrailkill, Evangelia Kalaitzoglou, John L Fowlkes> ;Frontiers in Pediatrics. 2022 Jan 1
• 3 citations
  Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes.
  Callie Travis, Priya S Srivastava, Thomas J Hawke, Evangelia Kalaitzoglou> ;Journal of Diabetes Research. 2022 Jan 1
• 5 citations
  Multilingual global e-learning pediatric endocrinology and diabetes curriculum for front line health care providers in resource-limited countries: Development study
  Evangelia Kalaitzoglou, Edna Majaliwa, Margaret Zacharin, Carine de Beaufort, Jean-Pierre Chanoine, Conny van Wijngaard-DeVugt, Ervin Sperla, Annemieke M. Boot, Stenve...> ;JMIR Formative Research. 2020 Nov 5
• 11 citations
  Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.
  Kathryn M. Thrailkill, R. Clay Bunn, Sasidhar Uppuganti, Philip D. Ray, Iuliana Popescu, Evangelia Kalaitzoglou, John L. Fowlkes, Jeffry S. Nyman> ;Bone. 2020 Sep 2
• 9 citations
  Muscle and serum myostatin expression in type 1 diabetes.
  Athan G. Dial, Cynthia M. F. Monaco, Grace K. Grafham, Nadya Romanova, Jeremy A. Simpson, Mark A. Tarnopolsky, Christopher G. R. Perry, Evangelia Kalaitzoglou, Thomas ...> ;Physiological Reports. 2020 Jul 1
• 13 citations
  Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype.
  John L. Fowlkes, R. Clay Bunn, Evangelia Kalaitzoglou, Phil Ray, Iuliana Popescu, Kathryn M. Thrailkill> ;Scientific Reports. 2020 Jun 1
• 7 citations
  Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization.
  John L. Fowlkes, R. Clay Bunn, Philip D. Ray, Evangelia Kalaitzoglou, Sasidhar Uppuganti, Mustafa Unal, Jeffry S. Nyman, Kathryn M. Thrailkill> ;Bone. 2020 Jan 1
• 24 citations
  TLR4 Promotes and DAP12 Limits Obesity-Induced Osteoarthritis in Aged Female Mice
  Evangelia Kalaitzoglou, Erika Barboza Prado Lopes, Yao Fu, Jacquelyn C Herron, Josiah Flaming, Elise L. Donovan, Yanqing Hu, Adrian Filiberti, Timothy M. Griffin, Mary...> ;JBMR Plus. 2019 Apr 1
• 59 citations
  Diabetes pharmacotherapy and effects on the musculoskeletal system
  Evangelia Kalaitzoglou, John L. Fowlkes, Iuliana Popescu, Kathryn M. Thrailkill> ;Diabetes/metabolism Research and Reviews. 2019 Feb 1
• 25 citations
  Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes.
  Jeffry S. Nyman, Evangelia Kalaitzoglou, R. Clay Bunn, Sasidhar Uppuganti, Kathryn M. Thrailkill, John L. Fowlkes> ;Bone Reports. 2017 Dec 1
• 68 citations
  Innate Immune Responses and Osteoarthritis.
  Evangelia Kalaitzoglou, Timothy M. Griffin, Mary Beth Humphrey> ;Current Rheumatology Reports. 2017 Jul 17
• 44 citations
  The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes
  Kathryn M. Thrailkill, Jeffry S. Nyman, R. Clay Bunn, Sasidhar Uppuganti, Katherine L. Thompson, Charles K. Lumpkin, Evangelia Kalaitzoglou, John L. Fowlkes> ;Bone. 2017 Jan 1
• 67 citations
  Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
  Evangelia Kalaitzoglou, Iuliana Popescu, R. Clay Bunn, John L. Fowlkes, Kathryn M. Thrailkill> ;Current Osteoporosis Reports. 2016 Oct 4
• 18 citations
  Air Displacement Plethysmography: Cradle to Grave
  David A. Fields, Ravindu Gunatilake, Evangelia Kalaitzoglou> ;Nutrition in Clinical Practice. 2015 Apr 1
• Join now to see all

Journal Articles

• Diabetes Pharmacotherapy and Effects on the Musculoskeletal System  
  Evangelia Kalaitzoglou, John L Fowlkes, Diabetes/Metabolism Research and Reviews